AKP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Anika Therapeutics Inc

Watchlist Manager

Watchlist

Price: 16.5 EUR -6.78% Market Closed

Market Cap: €240.7m

A	Anika Therapeutics Inc F:AKP	US
M	Muenchener Rueckversicherungs Gesellschaft in Muenchen AG F:MUVB	DE
W	Wharf Holdings Ltd XMUN:WHA	HK
	Australian Oil Company Ltd OTC:SGCSF	AU
A	Allegro.eu SA DUS:AL0	LU
M	MPC Container Ships ASA F:MP2	NO

Profitability Summary

Anika Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

61%

Gross Margin is Increasing

62% > 62%

Negative Operating Margin

-2%

Negative 3Y Average Operating Margin

-7%

Operating Margin is Increasing

-15% > -2%

Negative Net Margin

-3%

Negative 3Y Average Net Margin

-35%

Net Margin is Increasing

-15% > -3%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-7% > 0%

Negative ROE

-3%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-6%

ROIC is Increasing

-8% > -2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.